Company intelligence / Profile preview

Neobiomics

Solna, Stockholm, Sweden

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Neobiomics markets two evidence-based nutritional products for preterm infants: ProPrems, a multistrain probiotic food supplement, and NeoMega36, an arachidonic acid and docosahexaenoic acid-enriched oil classified as Food for Special Medical Purposes; products are supported by independent neonatal research and are commercially available across much of Europe.[1][3][4][7]

Therapeutic areas: OphthalmologyOtherNeurologyWomen's Health
Modalities: Live biotherapeutic product therapyMicrobial therapyOil-based nutritional productNon-pharmacological therapy
Industry: Food & Nutrition

Partnerships

ExCEEd Orphan (exclusive distribution partnership for ProPrems in Central and Eastern Europe and Baltics)[4]Chr. Hansen (manufacturer of ProPrems bacterial cultures)[4]Karolinska Institutet Innovation AB (innovation/incubator affiliation)[2][4]Various European university hospitals and research groups in Sweden, UK, France, Germany and Canada for clinical research collaborations[1]

Beyond the preview

Go deeper on Neobiomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neobiomics.

Explore the full profile